Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of the Vacucis Candida® Autovaccine in the Management of Chronic Oral Candidiasis. Randomized Triple-blind Randomized Clinical Trial.

NCT05289375 is registered in ClinicalTrials.gov with University of Santiago de Compostela as lead sponsor.

NCT NCT05289375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05289375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of the Vacucis Candida® Autovaccine in the Management of Chronic Oral Candidiasis. Randomized Triple-blind Randomized Clinical Trial.
Lead sponsor
University of Santiago de Compostela
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2025
Completion date
December 31, 2027
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

candida albicans infection, microbial colonization, oral candidiasis, oral candidiasis recurrent, radiotherapy; complications, xerostomia